Norepinephrine–dopamine releasing agent
Class of drugs that release norepinephrine and dopamine
A norepinephrine–dopamine releasing agent (NDRA) is a type of drug that induces the release of the neurotransmitters norepinephrine and dopamine in the brain. These agents are known for their stimulating effects and are used in various therapeutic and recreational contexts.
Mechanism of Action[edit]
NDRAs work by promoting the release of norepinephrine and dopamine from their storage sites in the presynaptic neuron into the synaptic cleft. This process increases the concentration of these neurotransmitters in the synaptic cleft, enhancing their action on postsynaptic receptors. The increased activity of norepinephrine and dopamine leads to heightened alertness, increased energy, and improved mood.
Pharmacological Effects[edit]
The primary effects of NDRAs are due to their action on the central nervous system. These effects include:
- Increased alertness and wakefulness: NDRAs can reduce fatigue and improve concentration.
- Enhanced mood: By increasing dopamine levels, these agents can produce feelings of euphoria and well-being.
- Appetite suppression: NDRAs can reduce appetite, which is why some are used in the treatment of obesity.
- Increased heart rate and blood pressure: Due to the action of norepinephrine, these agents can stimulate the cardiovascular system.
Therapeutic Uses[edit]
NDRAs are used in the treatment of several medical conditions, including:
- Attention deficit hyperactivity disorder (ADHD): Drugs like amphetamine are used to improve focus and reduce impulsivity in individuals with ADHD.
- Narcolepsy: NDRAs help manage excessive daytime sleepiness associated with narcolepsy.
- Obesity: Some NDRAs are used as appetite suppressants to aid in weight loss.
Examples of NDRAs[edit]
Several drugs fall under the category of NDRAs, including:
- Amphetamine: A well-known NDRA used in the treatment of ADHD and narcolepsy.
- Methamphetamine: A potent NDRA with high potential for abuse, used in some cases for ADHD and obesity.
- Phentermine: Used primarily as an appetite suppressant in the treatment of obesity.
Potential for Abuse and Dependence[edit]
Due to their stimulating effects and ability to produce euphoria, NDRAs have a high potential for abuse and dependence. Chronic use can lead to tolerance, requiring higher doses to achieve the same effects, and withdrawal symptoms upon cessation.
Safety and Side Effects[edit]
Common side effects of NDRAs include insomnia, anxiety, increased heart rate, and hypertension. Long-term use can lead to more serious health issues, such as cardiovascular problems and mental health disorders.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian